|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/395 | |||
| A61P 27/00 | |||
| C07K 14/00 | |||
| C07K 16/28 |
| (11) | Patento numeris | 2943218 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14701449.2 |
| Europos patento paraiškos padavimo data | 2014-01-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/010395 |
| Data | 2014-01-07 |
| (87) | Numeris | WO 2014/109999 |
| Data | 2014-07-17 |
| (30) | Numeris | Data | Šalis |
| 201361750437 P | 2013-01-09 | US | |
| 201361863452 P | 2013-08-08 | US | |
| 201361909421 P | 2013-11-27 | US |
| (72) |
WIEGAND, Stanley, J., US
LOBOV, Ivan, B., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | ANTI-PDGFR-BETA ANTIBODIES AND USES THEREOF |
| ANTI-PDGFR-BETA ANTIBODIES AND USES THEREOF |